A Durham, North Carolina-based company has now raised nearly $700,000 in a private stock offering, according to a filing with the Securities and Exchange Commission.

NeuroPlus Inc., whose flagship product shares a name with the company, filed the Form D on Wednesday. The company, which intends to raise a total of $1 million, did not indicate the intended use of the funds.

NeuroPlus describes itself as a product utilizing “innovative neurofeedback technology to help you practice focus and concentration,” according the company’s website.

While the Durham-based company’s product is not intended for treatment of any form of attention deficit disorder, a study by researchers at Duke University created hope the NeuroPlus might be used as a treatment for various types of attention deficit disorder.

“Parents were asking how we could use our technology to help improve attention and self-control, so NeuroPlus was created with the primary focus to develop a solution that children are comfortable with: video games,” CEO Jake Stauch said in a statement on the study. “We’re excited to see these results, showing NeuroPlus could address the needs of parents hoping to reduce inattention and hyperactivity in their children while also giving anyone, regardless of age, a way to sharpen and improve their focus.”

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but must file what’s known as a Form D electronically with the SEC after they first sell their securities.

The form can be found here.